Evidence map›Paper›PMID 42623146›Full record

ArticleJCI insight2026

The pleural tuberculosis-associated microenvironment promotes HIV-1 persistence by impairing CD8+ T cell-mediated viral control.

Samantha Cronin, Jennifer Simpson, Andrea Pereyra-Casanova, Yuchen Li, Josefina Marín-Rojas, Freja A Warner van Dijk, Katie Fisher, Daniel J Buffa, Hafsa Rana, Zoï Vahlas and 14 more

Abstract read
PubMed Publisher
In one paragraph

Article in JCI insight, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Samantha CroninCentre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia.
Jennifer SimpsonCentre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia.
Andrea Pereyra-CasanovaCentre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia.
Yuchen LiCentre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia.
Josefina Marín-RojasCentre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia.
Freja A Warner van DijkCentre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia.
Katie FisherCentre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia.
Daniel J BuffaCentre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia.
Hafsa RanaCentre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia.
Zoï VahlasInstitut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France.
Joaquina BarrosDepartamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina.
Mariano MaioDepartamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina.
Thomas R O'NeilCentre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia.
Kirstie M BertramCentre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia.
Eunok LeeCentre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia.
Najla NasrCentre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia.
Andrew N HarmanCentre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia.
Gabriela TurkDepartamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina.
Maria Florencia QuirogaDepartamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina.
Anthony D KelleherThe Kirby Institute, University of New South Wales, Sydney, Australia.
Christel VérolletMécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France.
Luciana BalboaDepartamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina.
Sarah PalmerCentre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia.
Gabriel DuetteCentre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycobacteriumtuberculosis (Mtb), the causative agent of tuberculosis (TB), is the most common coinfection in people living with HIV-1 (PLWH). This coinfection is associated with accelerated HIV-1 disease progression and reduced survival. However, the immunological and virological mechanisms driving this progression are not completely understood. To address this knowledge gap, using pleural effusion samples from PLWH and TB, we investigated how the HIV-1 genetic landscape and the anti-HIV-1 immune response are impacted by a TB-associated microenvironment. Our results revealed an enrichment of genetically intact HIV-1 and impaired CD8+ T cell-mediated antiviral response at this site of HIV-1/Mtb coinfection. Moreover, efficient CD8+ T cell activation was inhibited by lipids present in the TB-associated pleural effusion. These findings indicate that this immune microenvironment induced by TB promotes the persistence of cells infected with replication-competent HIV-1 by creating a niche of reduced antiviral immune pressure, potentially contributing to the worsened clinical outcomes observed in PLWH and TB.

Indexed as

AIDS/HIVImmunologyInfectious diseaseTuberculosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.